Blueprint Medicines CorporationBlueprint Medicines CorporationBlueprint Medicines Corporation

Blueprint Medicines Corporation

No trades
See on Supercharts

Price target

125.580.000.00%
The 19 analysts offering 1 year price forecasts for BPMC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 20 analysts giving stock ratings to BPMC in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BPMC EPS for the last quarter is −0.89 USD despite the estimation of −0.96 USD. In the next quarter EPS is expected to reach −0.70 USD. Track more of Blueprint Medicines Corporation financials and stay on top of what is up with the company.
In the next quarter Blueprint Medicines Corporation revenue is expected to reach ‪146.14 M‬ USD. Check out Blueprint Medicines Corporation revenue and earnings and make informed decisions.
According to analysts, BPMC price target is 125.58 USD with a max estimate of 167.00 USD and a min estimate of 81.00 USD. Check if this forecast comes true in a year, meanwhile watch Blueprint Medicines Corporation stock price chart and keep track of the current situation with BPMC news and stock market news.
We've gathered opinions of 20 analysts rating BPMC stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.